Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-26-037458
Filing Date
2026-08-12
Accepted
2026-08-12 17:29:38
Documents
76
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 1215661
2 EX-31.1 ex31-1.htm EX-31.1 17470
3 EX-31.2 ex31-2.htm EX-31.2 17615
4 EX-32.1 ex32-1.htm EX-32.1 7801
5 EX-32.2 ex32-2.htm EX-32.2 7724
  Complete submission text file 0001493152-26-037458.txt   7118943

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cdt-20260630.xsd EX-101.SCH 59719
7 XBRL CALCULATION FILE cdt-20260630_cal.xml EX-101.CAL 69456
8 XBRL DEFINITION FILE cdt-20260630_def.xml EX-101.DEF 297456
9 XBRL LABEL FILE cdt-20260630_lab.xml EX-101.LAB 489324
10 XBRL PRESENTATION FILE cdt-20260630_pre.xml EX-101.PRE 398916
79 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 988458
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CDT Equity Inc. (Filer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41245 | Film No.: 261268916
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)